These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28087808)

  • 1. Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics.
    Li N; Wang X; Xu Y; Lin Y; Zhu N; Liu P; Lu D; Si S
    Mol Pharmacol; 2017 Apr; 91(4):264-276. PubMed ID: 28087808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel partial agonist of liver X receptor α (LXRα) via screening.
    Li N; Wang X; Zhang J; Liu C; Li Y; Feng T; Xu Y; Si S
    Biochem Pharmacol; 2014 Dec; 92(3):438-47. PubMed ID: 25450668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
    Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
    Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.
    Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S
    J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of liver X receptor agonist TO901317 on cognitive function in APP/PS1 double transgenic mice with Alzheimer
    Luo Y; Tan X; Zhang X; Li Y; Huang J; Deng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1324-1331. PubMed ID: 36411683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice.
    Zhang Y; Breevoort SR; Angdisen J; Fu M; Schmidt DR; Holmstrom SR; Kliewer SA; Mangelsdorf DJ; Schulman IG
    J Clin Invest; 2012 May; 122(5):1688-99. PubMed ID: 22484817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
    Kaseda R; Tsuchida Y; Yang HC; Yancey PG; Zhong J; Tao H; Bian A; Fogo AB; Linton MRF; Fazio S; Ikizler TA; Kon V
    BMC Nephrol; 2018 Jan; 19(1):17. PubMed ID: 29374468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
    Breevoort SR; Angdisen J; Schulman IG
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of protein arginine methyltransferase 3 activity selectively impairs liver X receptor-driven transcription of hepatic lipogenic genes in vivo.
    Nahon JE; Groeneveldt C; Geerling JJ; van Eck M; Hoekstra M
    Br J Pharmacol; 2018 Aug; 175(15):3175-3183. PubMed ID: 29774529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhage.
    Wu CH; Chen CC; Lai CY; Hung TH; Lin CC; Chao M; Chen SF
    J Neuroinflammation; 2016 Mar; 13(1):62. PubMed ID: 26968836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in LXR signaling influence early-pregnancy lipogenesis and protect against dysregulated fetoplacental lipid homeostasis.
    Nikolova V; Papacleovoulou G; Bellafante E; Borges Manna L; Jansen E; Baron S; Abu-Hayyeh S; Parker M; Williamson C
    Am J Physiol Endocrinol Metab; 2017 Oct; 313(4):E463-E472. PubMed ID: 28420650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of LXRα induces lipogenesis in HaCaT cells.
    Hong I; Rho HS; Kim DH; Lee MO
    Arch Pharm Res; 2010 Sep; 33(9):1443-9. PubMed ID: 20945144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.
    Taylor JM; Borthwick F; Bartholomew C; Graham A
    Cardiovasc Res; 2010 Jun; 86(3):526-34. PubMed ID: 20083572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages.
    Vinod M; Chennamsetty I; Colin S; Belloy L; De Paoli F; Schaider H; Graier WF; Frank S; Kratky D; Staels B; Chinetti-Gbaguidi G; Kostner GM
    Biochim Biophys Acta; 2014 Jun; 1841(6):827-35. PubMed ID: 24603323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
    Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X receptor activation increases hepatic fatty acid desaturation by the induction of SCD1 expression through an LXRα-SREBP1c-dependent mechanism.
    Zhang X; Liu J; Su W; Wu J; Wang C; Kong X; Gustafsson JÅ; Ding J; Ma X; Guan Y
    J Diabetes; 2014 May; 6(3):212-20. PubMed ID: 23945440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression.
    Guo Y; Yuan W; Yu B; Kuai R; Hu W; Morin EE; Garcia-Barrio MT; Zhang J; Moon JJ; Schwendeman A; Eugene Chen Y
    EBioMedicine; 2018 Feb; 28():225-233. PubMed ID: 29361501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.